What is in the report a patient hands you?
Six measures from the weeks before the appointment, logged as they happened rather than remembered in the room, and laid out in a structure built for review.
Concentration curve
Modelled from published population pharmacokinetic parameters for the medication and dose, then calibrated after 14 days to the patient's own observed duration of effect.
Adherence and dose timing
Logged dose events against the patient's stated prescription schedule. Unlogged days appear as gaps, not as missed doses.
Focus, sleep and wear off
Patient self ratings aggregated week by week, with sleep optionally synced from the phone's health platform. Wear off compares the reported offset against the modelled curve.
Blood pressure and heart rate
Patient entered or monitor synced readings, grouped by dose period so cardiovascular changes can be read against dose changes.
Side effects and dose comparison
Side effects are patient tagged with optional intensity, tracked against dose changes. Where more than one dose has been logged, every measure is summarised per dose level.
Discussion points
Notable patterns phrased as questions for the appointment, never conclusions. The report closes with the conversation it is meant to start.
What patients are asked to log through titration, and why each measure earns its place, is set out in plain terms in our guide to tracking titration.
* ADHDose is a consumer diary, not a regulated medical device. It does not diagnose, dose or advise, and the report is not clinically validated. All inputs are self reported. It exists to give clinicians a fuller picture of the weeks between appointments than recall alone.
Which medications and regions does ADHDose cover?
ADHDose covers the UK, EU and US prescribing sets, and the report follows local practice in each market. The medications, the monitoring expectations and the care pathways all differ by country, so the detail changes. What the report contains, and how each figure is derived, does not.
The lists themselves are public: every medication we model is set out on our UK medications and US medications pages.
What do prescribers ask us first?
Usually the same five questions, and mostly about provenance rather than features. Here they are with the answers we would give you on a call, including the one about what the report cannot do.
Where does the concentration curve come from?
Is ADHDose a medical device?
Can the patient edit or delete their data before sharing it?
Does ADHDose see patient data?
What does the report not tell me?
How can a service work with ADHDose?
Three ways, and the first needs no agreement at all: a clinician toolkit, a structured pilot with a cohort of your patients through titration, or a commercial partnership if you want ADHDose woven into your pathway. There is nothing for your team to administer. ADHDose is independent and early, which is exactly when partnership shapes the product.
Clinician toolkit
A sample report, a one page methodology summary for your team, and patient facing material for your service to hand out.
Free · No agreement neededStructured pilot
Run ADHDose with a cohort of your patients through titration. We work with your clinical team on setup, and you tell us what the report is missing.
You choose the cohortCommercial partnership
For providers and organisations who want ADHDose woven into their pathway. Co designed and commercially structured.
Scoped together"I've been through the system myself. The long waits, the gaps between appointments, all the while trying to remember everything to feedback by my next one. ADHDose exists to fill that gap."
Tell us where it hurts.
If you want your patients to have the tools to set themselves up for success, and you want structured, patient-logged data to review at baseline, during titration and while they're settled on a dose, we'd love to see how we can help.
Just want the sample report? Ask for it in the message and we will send it straight over. Research and press: support@adhdose.com.
ADHDose is built by ADHDOSE LTD, a UK company registered in England and Wales. Its founder takes ADHD medication himself, and the product began as the tool he needed. The app supports conversations with prescribers, never replaces them.